|
Walker, Ellen A; Young, Alice M (2002) Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine. J Pharmacol Exp Ther 302:101-10
|
|
Walker, E A; Young, A M (2001) Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Psychopharmacology (Berl) 154:131-42
|
|
Walker, E A; Zernig, G; Young, A M (1998) In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assay. Psychopharmacology (Berl) 136:15-23
|
|
Makhay, M M; Young, A M; Poling, A (1998) Establishing morphine and U-50,488H as discriminative stimuli in a three-choice assay with pigeons. Exp Clin Psychopharmacol 6:3-9
|
|
Walker, E A; Richardson, T M; Young, A M (1997) Tolerance and cross-tolerance to morphine-like stimulus effects of mu opioids in rats. Psychopharmacology (Berl) 133:17-28
|
|
Young, A M; McMullen, W J; Makhay, M M et al. (1996) Behavioral contingencies modulate tolerance to discriminative stimulus effects of morphine. Psychopharmacology (Berl) 125:220-30
|
|
Walker, E A; Richardson, T M; Young, A M (1996) In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine. Psychopharmacology (Berl) 125:113-9
|
|
Walker, E A; Makhay, M M; House, J D et al. (1994) In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats. J Pharmacol Exp Ther 271:959-68
|
|
Walker, E A; Young, A M (1993) Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine. J Pharmacol Exp Ther 267:322-30
|
|
Young, A M; Masaki, M A; Geula, C (1992) Discriminative stimulus effects of morphine: effects of training dose on agonist and antagonist effects of mu opioids. J Pharmacol Exp Ther 261:246-57
|
Showing the most recent 10 out of 15 publications
